Multidrug-resistant infections are a growing global threat, driven by diverse bacterial resistance mechanisms, complicating efforts to develop effective, long-lasting antibiotics.
Author: meenatekkalakote24
The drug entacapone disrupts the gut microbiome, leading to implications for host health.
CRISPR-Cas9, a powerful gene-editing tool, protects probiotics from antibiotic resistance and presents a promising strategy to combat bacterial infections